Four students (from left above: Sophie Liddell, Sejal Sathe, Rahnya Taghi, and Jessie Siling Li)—who have never actually met each other—jointly contributed to the recent study “A second genetic screen for gurken mRNA mislocalisation uncovers novel phenotypes of piRNA pathway mutants in Drosophila”, published in Biology Open. The work was led by Rippei Hayashi in the Genome Science and Cancer Division and the Shine-Dalgarno Centre for RNA Innovation.

A new international study led by Professor David Tremethick at the ANU John Curtin School of Medical Research and Professor Jonas Paulsen from the University of Oslo, has revealed how the three-dimensional structure of the human genome is dramatically reorganised during breast cancer progression.

Vijay Bhoopalan shares with us his passions and his health research journey.

Could tiny ‘molecular robots’ made from RNA provide personalised cancer treatments – without the harmful side effects?

ANU spinoff company Ability Optics Pty Ltd is accelerating to revolutionise biotechnology with an aim to speed up early lead drug screening by 100-fold.

New research provides insight into how cells identify and discard faulty molecular machines responsible for RNA splicing.